Replies to post #628 on Sonnet BioTherapeutics Inc (SONN)

[BiotechValues]

I'm buying back now, yes.
I bought the first rights offering early in year and that set the bottom for the stock.
This will be a repeat of that, with $1.35 rights offering (priced today) setting the bottom. Expect news soon that will get it going again.
Obviously a very weak market right now- but low gas prices = good news for fast casual restaurant growth.
Also have spoken with the CEO on several occasions and like his style, brains, and ability to execute.